{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:41:02Z","timestamp":1790995262111,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.resinv.2022.04.002","type":"journal-article","created":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T17:20:31Z","timestamp":1651252831000},"page":"522-530","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Pathophysiological mechanism of non-HIV Pneumocystis jirovecii pneumonia"],"prefix":"10.1016","volume":"60","author":[{"given":"Nobuhiro","family":"Asai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Motojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ohkuni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Matsunuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamao","family":"Nakashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2022.04.002_bib1","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMra032588","article-title":"Pneumocystis pneumonia","volume":"350","author":"Thomas","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib2","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1001\/jama.2009.880","article-title":"Evolving health effects of Pneumocystis: one hundred years of progress in diagnosis and treatment","volume":"301","author":"Kovacs","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.resinv.2022.04.002_bib3","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1164\/ajrccm\/140.5.1204","article-title":"Pneumocystis carinii pneumonia. Differences in lung parasite number and inflammation in patients with and without AIDS.","volume":"140","author":"Limper","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3109\/s10165-010-0406-3","article-title":"Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis","volume":"21","author":"Koike","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2022.04.002_bib5","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib6","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/JCM.02016-07","article-title":"Molecular evidence of nosocomial Pneumocystis jirovecii transmission among 16 patients after kidney transplantation","volume":"46","author":"Schmoldt","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2022.04.002_bib7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/513198","article-title":"An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source?","volume":"44","author":"de Boer","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3201\/eid2009.131668","article-title":"Pneumocystis jirovecii pneumonia in patients with or without AIDS, France","volume":"20","author":"Roux","year":"2014","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/2049-6958-7-2","article-title":"Non-HIV Pneumocystis pneumonia: do conventional community-acquired pneumonia guidelines under estimate its severity?","volume":"7","author":"Asai","year":"2012","journal-title":"Multidiscip Respir Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib10","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10156-012-0441-4","article-title":"Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection","volume":"18","author":"Asai","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2022.04.002_bib11","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1128\/JCM.42.7.3333-3335.2004","article-title":"Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods","volume":"42","author":"Procop","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2022.04.002_bib12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.3899\/jrheum.081270","article-title":"A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis","volume":"36","author":"Mori","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.resinv.2022.04.002_bib13","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1128\/JCM.01756-09","article-title":"Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy","volume":"47","author":"Desmet","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.resinv.2022.04.002_bib14","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1469-0691.2010.03318.x","article-title":"Serum (1--> 3)-beta-D-glucan measurement as an early indicator of Pneumocystis jirovecii pneumonia and evaluation of its prognostic value","volume":"17","author":"Held","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resinv.2022.04.002_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2169\/internalmedicine.48.1680","article-title":"Clinical utility of serum beta-D-glucan and KL-6 levels in Pneumocystis jirovecii pneumonia","volume":"48","author":"Nakamura","year":"2009","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2169\/internalmedicine.37.307","article-title":"KL-6 as a serologic indicator of Pneumocystis carinii pneumonia in immunocompromised hosts","volume":"37","author":"Hamada","year":"1998","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib17","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1378\/chest.06-1467","article-title":"Serum indicators for the diagnosis of pneumocystis pneumonia","volume":"131","author":"Tasaka","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2022.04.002_bib18","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1086\/605579","article-title":"Serum (1-->3) beta-D-glucan as a noninvasive adjunct marker for the diagnosis of Pneumocystis pneumonia in patients with AIDS","volume":"49","author":"Watanabe","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"379","key":"10.1016\/j.resinv.2022.04.002_bib19","first-page":"e1","article-title":"Diagnosis of Pneumocystis pneumonia: evaluation of four serologic biomarkers","volume":"21","author":"Esteves","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resinv.2022.04.002_bib20","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s10156-012-0415-6","article-title":"A successful diagnostic case of Pneumocystis pneumonia by the loop-mediated isothermal amplification method in a patient with dermatomyositis","volume":"18","author":"Asai","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2022.04.002_bib21","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jiac.2014.08.005","article-title":"Loop-mediated isothermal amplification method for diagnosing Pneumocystis pneumonia in HIV-uninfected immunocompromised patients with pulmonary infiltrates","volume":"20","author":"Nakashima","year":"2014","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2022.04.002_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jiac.2014.09.004","article-title":"Loop-mediated isothermal amplification with the Procedure for Ultra Rapid Extraction kit for the diagnosis of pneumocystis pneumonia","volume":"21","author":"Kawano","year":"2015","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.resinv.2022.04.002_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1378\/chest.107.1.107","article-title":"Evaluation of a prognostic score. Pneumocystis carinii pneumonia in HIV-infected patients","volume":"107","author":"Vanhems","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2022.04.002_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jinf.2014.02.015","article-title":"Prognostic factors of Pneumocystis jirovecii pneumonia in patients without HIV infection","volume":"69","author":"Kim","year":"2014","journal-title":"J Infect"},{"key":"10.1016\/j.resinv.2022.04.002_bib25","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2169\/internalmedicine.50.5296","article-title":"Kinetics of serum beta-D-glucan after Pneumocystis pneumonia treatment in patients with AIDS","volume":"50","author":"Koga","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib26","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2334-11-76","article-title":"Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes","volume":"11","author":"Matsumura","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib27","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cmi.2021.08.017","article-title":"Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis","volume":"28","author":"Senecal","year":"2022","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resinv.2022.04.002_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2169\/internalmedicine.47.0702","article-title":"Clinical and radiological features of Pneumocystis pneumonia in patients with rheumatoid arthritis, in comparison with methotrexate pneumonitis and\u00a0Pneumocystis pneumonia in acquired immunodeficiency syndrome: a multicenter study","volume":"47","author":"Tokuda","year":"2008","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib29","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2169\/internalmedicine.50.4508","article-title":"Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study","volume":"50","author":"Kameda","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1159\/000477332","article-title":"Clinical manifestations and prognostic factors of Pneumocystis jirovecii pneumonia without HIV","volume":"62","author":"Asai","year":"2017","journal-title":"Chemotherapy"},{"key":"10.1016\/j.resinv.2022.04.002_bib31","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2169\/internalmedicine.49.2871","article-title":"Comparison of clinical and radiological features of pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: a multicenter study","volume":"49","author":"Tasaka","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2169\/internalmedicine.45.1691","article-title":"The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations","volume":"45","author":"Miyashita","year":"2006","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib33","first-page":"56","article-title":"BTS guidelines for the management of community acquired pneumonia in adults","author":"British Thoracic Society Standards of Care C","year":"2001","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2022.04.002_bib34","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.resinv.2022.04.002_bib35","first-page":"S4","article-title":"Establishment of new severity ratings based on analysis of hospital-acquired pneumonia","volume":"14","author":"Japanese Respiratory","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2022.04.002_bib36","doi-asserted-by":"crossref","first-page":"e318","DOI":"10.1016\/j.ijid.2012.05.358","article-title":"The predictive rule for the management of hospital-acquired pneumonia in adults by the Japanese Respiratory Society, I-ROAD, could correctly estimate the severity of Pneumocystis Pneumonia without human immunodeficiency virus infection","volume":"16","author":"Asai","year":"2012","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib37","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.3201\/eid2308.ET2308","article-title":"Etymologia: Pneumocystis jirovecii","volume":"23","author":"Henry","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.arbres.2016.06.016","article-title":"Adjunctive corticosteroids for Pneumocystis jirovecii pneumonia in non-HIV-infected patients: a systematic review and meta-analysis of observational studies","volume":"53","author":"Fujikura","year":"2017","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.resinv.2022.04.002_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006150.pub2","article-title":"Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV infection","author":"Ewald","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.resinv.2022.04.002_bib40","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1080\/14656566.2021.1915989","article-title":"Pneumocystis jirovecii: a review with a focus on prevention and treatment","volume":"22","author":"Weyant","year":"2021","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.resinv.2022.04.002_bib41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000507540","article-title":"The first report on pharmacokinetic\/pharmacodynamic study of trimethoprim\/sulfamethoxazole against Staphylococcus aureus with a neutropenic murine thigh infection model","volume":"64","author":"Hagihara","year":"2019","journal-title":"Chemotherapy"},{"key":"10.1016\/j.resinv.2022.04.002_bib42","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/infdis\/171.5.1295","article-title":"Adverse events associated with trimethoprim-sulfamethoxazole and atovaquone during the treatment of AIDS-related Pneumocystis carinii pneumonia","volume":"171","author":"Hughes","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib43","doi-asserted-by":"crossref","first-page":"e13737","DOI":"10.1111\/tid.13737","article-title":"The effectiveness and safety of low dose trimethoprim-sulfamethoxazole for the treatment of pneumocystis pneumonia: a systematic review and meta-analysis","volume":"23","author":"Tritle","year":"2021","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib44","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa112","article-title":"Low-dose TMP-SMX in the treatment of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis","volume":"7","author":"Butler-Laporte","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.resinv.2022.04.002_bib45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12119","article-title":"Practice ASTIDCo. Pneumocystis pneumonia in solid organ transplantation","volume":"13","author":"Martin","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.resinv.2022.04.002_bib46","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/cid\/ciy154","article-title":"Pneumocystis cytochrome b mutants associated with atovaquone prophylaxis failure as the cause of pneumocystis infection outbreak among heart transplant recipients","volume":"67","author":"Argy","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib47","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2165\/00002018-199005030-00006","article-title":"risk-benefit analysis","volume":"5","author":"Wispelwey","year":"1990","journal-title":"Drug Saf"},{"key":"10.1016\/j.resinv.2022.04.002_bib48","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.resinv.2022.04.002_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.semarthrit.2011.05.004","article-title":"Primary prophylaxis for Pneumocystis jirovecii pneumonia in patients with connective tissue diseases","volume":"41","author":"Vananuvat","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.resinv.2022.04.002_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/ar2826","article-title":"Value of anti-infective chemoprophylaxis in primary systemic vasculitis: what is the evidence?","volume":"11","author":"Moosig","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.resinv.2022.04.002_bib51","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/rheumatology\/kem146a","article-title":"BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis","volume":"46","author":"Lapraik","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.resinv.2022.04.002_bib52","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJM198706253162604","article-title":"Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"316","author":"Hughes","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib53","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJM197712292972602","article-title":"Successful chemoprophylaxis for Pneumocystis carinii pneumonitis","volume":"297","author":"Hughes","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib54","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.4065\/82.9.1052","article-title":"Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials","volume":"82","author":"Green","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.resinv.2022.04.002_bib55","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199503163321101","article-title":"A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. NIAID AIDS Clinical Trials Group","volume":"332","author":"Bozzette","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib56","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/jcp.44.10.820","article-title":"Disseminated pneumocystis carinii infection in AIDS","volume":"44","author":"Coker","year":"1991","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.resinv.2022.04.002_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1001058","article-title":"Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia","volume":"6","author":"Wang","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.resinv.2022.04.002_bib58","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/14397595.2018.1465647","article-title":"Effect of sulfasalazine use on the presence of Pneumocystis organisms in the lung among patients with rheumatoid arthritis: a test-negative design case-control study with PCR tests","volume":"29","author":"Nunokawa","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.resinv.2022.04.002_bib59","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199011223232104","article-title":"A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"323","author":"Bozzette","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib60","first-page":"85","article-title":"Differential macrophage polarization from pneumocystis in immunocompetent and immunosuppressed hosts: potential\u00a0adjunctive therapy during pneumonia","author":"Nandakumar","year":"2017","journal-title":"Infect Immun"},{"key":"10.1016\/j.resinv.2022.04.002_bib61","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cell.2019.08.010","article-title":"Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans","volume":"178","author":"Hagan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.resinv.2022.04.002_bib62","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.celrep.2019.05.105","article-title":"Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection","volume":"28","author":"Bradley","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.resinv.2022.04.002_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004923","article-title":"The lung microbiome: new principles for respiratory bacteriology in health and disease","volume":"11","author":"Dickson","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.resinv.2022.04.002_bib64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2020.03.012","article-title":"Microbiota-immune interactions in asthma pathogenesis and phenotype","volume":"66","author":"Lukacs","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.resinv.2022.04.002_bib65","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jaci.2015.05.044","article-title":"The airway microbiome in patients with severe asthma: associations with disease features and severity","volume":"136","author":"Huang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.resinv.2022.04.002_bib66","first-page":"22","article-title":"The lung microbiome during health and disease","author":"Yagi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.resinv.2022.04.002_bib67","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jgar.2021.10.009","article-title":"COVID-19 disease severity is linked to host immunity as well as lung and gut dysbiosis: a narrative review","volume":"27","author":"Asai","year":"2021","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.resinv.2022.04.002_bib68","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12890-017-0512-5","article-title":"The lung microbiome in patients with pneumocystosis","volume":"17","author":"Kehrmann","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2022.04.002_bib69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3201\/eid1102.040487","article-title":"Pneumocystis jirovecii in general population","volume":"11","author":"Medrano","year":"2005","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.resinv.2022.04.002_bib70","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1469-0691.2005.01337.x","article-title":"Pneumocystis jirovecii colonisation in patients with interstitial lung disease","volume":"12","author":"Vidal","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.resinv.2022.04.002_bib71","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/thoraxjnl-2012-202917","article-title":"Microbial communities in the respiratory tract of patients with interstitial lung disease","volume":"68","author":"Garzoni","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2022.04.002_bib72","doi-asserted-by":"crossref","first-page":"500","DOI":"10.3389\/fimmu.2014.00500","article-title":"Phenotypic diversity and emerging new tools to study macrophage activation in bacterial infectious diseases","volume":"5","author":"Ka","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.resinv.2022.04.002_bib73","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.chom.2012.09.009","article-title":"Intestinal commensal microbes as immune modulators","volume":"12","author":"Ivanov","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.resinv.2022.04.002_bib74","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.4049\/jimmunol.1303369","article-title":"Protection from intestinal inflammation by bacterial exopolysaccharides","volume":"192","author":"Jones","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.resinv.2022.04.002_bib75","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.chom.2013.05.013","article-title":"A single strain of Clostridium butyricum induces intestinal IL-10-producing macrophages to suppress acute experimental colitis in mice","volume":"13","author":"Hayashi","year":"2013","journal-title":"Cell Host Microbe"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534522000466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534522000466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:33:09Z","timestamp":1761949989000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534522000466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":75,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2212534522000466"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2022.04.002","relation":{},"ISSN":["2212-5345"],"issn-type":[{"value":"2212-5345","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiological mechanism of non-HIV Pneumocystis jirovecii pneumonia","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2022.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Respiratory Society. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}